| [1] |
ES-SABBAHI B, SERRAJ M, ALAMI B, et al. AB thymoma revealed by a huge intraparenchymal lung mass: a case report[J]. 2021, 38: 189.
|
| [2] |
ROBINSON S P, AKHONDI H. Thymoma[J]. Treasure Island (FL): StatPearls Publishing, 2025.[Online ahead of print]
|
| [3] |
ZHANG Y, LIN D, ARAMINI B, et al. Thymoma and thymic carcinoma: surgical resection and multidisciplinary treatment[J]. Cancers (Basel), 2023, 15(7): 1953.
|
| [4] |
MANGLA A, HAMAD H. Pure red cell aplasia[J]. Treasure Island (FL): StatPearls Publishing; 2025.[Online ahead of print]
|
| [5] |
SOITONG P, NGATHAWEESUK Y, PANYAYINGYONG N, et al. Multicenter analysis of acute retinal necrosis: clinical characteristics, viral pathogens, and diagnostic predictive factors[J]. Ocul Immunol Inflamm, 2025, 33(5): 721-728.
|
| [6] |
SAKATA R, CHU P S, KAWAIDA M, et al. Concurrent de novo thymoma-associated paraneoplastic type 1 autoimmune hepatitis and pure red cell aplasia after thymectomy: a case report and literature review[J]. Intern Med, 2023, 62(2): 243-249.
|
| [7] |
SHIRAFKAN F, HENSEL L, RATTAY K. Immune tolerance and the prevention of autoimmune diseases essentially depend on thymic tissue homeostasis[J]. Front Immunol, 2024, 15: 1339714.
|
| [8] |
AO Y Q, GAO J, WANG S, et al. Immunotherapy of thymic epithelial tumors: molecular understandings and clinical perspectives[J]. Mol Cancer, 2023, 22(1): 70.
|
| [9] |
ZHAO J, BHATNAGAR V, DING L, et al. A systematic review of paraneoplastic syndromes associated with thymoma: treatment modalities, recurrence, and outcomes in resected cases[J]. J Thorac Cardiovasc Surg, 2020, 160(1): 306-314.e14.
doi: S0022-5223(19)34023-1
pmid: 31982129
|
| [10] |
RIELY G J, WOOD D E, LOO B W, et al. Thymomas and thymic carcinomas, version 2. 2025, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2025, 23(6): 255-269.
|
| [11] |
SHIBATA M, KANEKO K, UMEHARA N, et al. A pregnant woman with thymoma-associated pure red cell aplasia[J]. BMC Pregnancy Childbirth, 2022, 22(1): 795.
|
| [12] |
HIROKAWA M, SAWADA K I, FUJISHIMA N, et al. Long-term response and outcome following immunosuppressive therapy in thymoma-associated pure red cell aplasia: a nationwide cohort study in Japan by the PRCA collaborative study group[J]. Haematologica, 2008, 93(1): 27-33.
doi: 10.3324/haematol.11655
pmid: 18166782
|
| [13] |
ABDULGAYOOM M, GANWO I, ATA F, et al. Successful management of post-thymectomy pure red cell aplasia with rituximab: a case report[J]. Case Rep Oncol, 2025, 18(1): 100-106.
doi: 10.1159/000542915
pmid: 39980504
|
| [14] |
MURATORI L, DELCURATOLO M D, SPERONE P, et al. Discrepancy between tumor response and hematologic response in a patient with thymoma and aplastic anemia treated with ciclosporin[J]. Mediastinum, 2020, 4: 8.
doi: 10.21037/med.2020.03.01
pmid: 35118276
|
| [15] |
LOBBES H. Pure red cell aplasia: Diagnosis, classification and treatment[J]. Rev Med Interne, 2023, 44(1): 19-26.
|
| [16] |
LIU M Y, HE X M, ZHANG H Q, et al. Aberrant hematopoiesis and CD8+ T-cell activation in thymoma-associated pure red cell aplasia[J]. Thorac Cancer, 2025, 16(6): e70046.
|
| [17] |
KOOSHESH K A, FOY B H, SYKES D B, et al. Health consequences of thymus removal in adults[J]. N Engl J Med, 2023, 389(5): 406-417.
|
| [18] |
HU Q, LIU Y, YUE Q, et al. Lenalidomide-induced pure red cell aplasia is associated with elevated expression of MHC-Ⅰ molecules on erythrocytes[J]. Nat Commun, 2024, 15(1): 10131.
|
| [19] |
PADHI P. Successful treatment of nivolumab plus ipilimumab-mediated pure red-cell aplasia and diabetes with cyclosporine[J]. J Hematol Oncol Pharm, 2021, 11(5): 264-268
|
| [20] |
KALOGEROPOULOS D, AFSHAR F, KALOGEROPOULOS C, et al. Diagnostic and therapeutic challenges in acute retinal necrosis; an update[J]. Eye, 2024, 38: 1816-1826.
|
| [21] |
MIMURA T, MIZOTA A, WATANABE E, et al. A single-center case series of acute retinal necrosis at Teikyo university: clinical characteristics and treatment outcomes[J]. Cureus, 2024, 16(6): e62343.
|
| [22] |
THAWLEY J, COLBERT C, EILBERT W. Acute retinal necrosis[J]. Am J Emerg Med, 2024, 82: 216. e1-216.e3.
|
| [23] |
SHIEZADEH E, HOSSEINI S M, BAKHTIARI E, et al. Clinical characteristics and management outcomes of acute retinal necrosis[J]. Sci Rep, 2023, 13(1): 16927.
|
| [24] |
NGUYEN N M, CONRADY C D. A better understanding of the clinical and pathological changes in viral retinitis: steps to improve visual outcomes[J]. Microorganisms, 2024, 12(12): 2513.
|
| [25] |
REX V, ZARGARI R, STEMPEL M, et al. The innate and T-cell mediated immune response during acute and chronic gammaherpesvirus infection[J]. Front Cell Infect Microbiol, 2023, 13: 1146381.
|
), 郑玉菡2(
